Sutro Biopharma Presents Promising Preclinical Data For Pipeline ADC Programs At AACR 2026

AI Briefing

• – Sutro Biopharma presents promising preclinical data for its ADC pipeline at AACR 2026.
• – The company's pipeline includes five posters and one oral presentation.
• – Data highlights include ADC programs targeting various cancer types.